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A B S T R A C T
Deficient learning and memory are well-established pathophysiologic features of depression, however, me-
chanisms of the enhanced learning of aversive experiences associated with this disorder are poorly understood.
Currently, neurobiological mechanisms of enhanced retention of aversive memories during depression, and, in
particular, their relation to neuroinflammation are unclear. As the association between major depressive dis-
order and inflammation has been recognized for some time, we aimed to address whether neuroinflammatory
changes are involved in enhanced learning of adversity in a depressive state. To study this question, we used a
recently described mouse model of enhanced contextual conditioning of aversive memories, the modified forced
swim model (modFST). In this model, the classic two-day forced swim is followed by an additional delayed
session on Day 5, where increased floating behaviour and upregulated glycogen synthase kinase-3 (GSK-3) are
context-dependent. Here, increased time spent floating on Day 5, a parameter of enhanced learning of the
adverse context, was accompanied by hypercorticosteronemia, increased gene expression of GSK-3α, GSK-3β, c-
Fos, cyclooxygenase-1 (COX-1) and pro-inflammatory cytokines interleukin-1 beta (IL-1β), tumor necrosis factor
(TNF), and elevated concentrations of protein carbonyl, a marker of oxidative stress, in the prefrontal cortex and
hippocampus. There were significant correlations between cytokine levels and GSK-3β gene expression. Two-
week administration of compounds with antidepressant properties, imipramine (7 mg/kg/day) or thiamine
(vitamin B1; 200 mg/kg/day) ameliorated most of the modFST-induced changes. Thus, enhanced learning of
adverse memories is associated with pro-inflammatory changes that should be considered for optimizing
pharmacotherapy of depression associated with enhanced learning of aversive memories.
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While compromised brain plasticity is a well-established patho-
physiologic feature of depression, little is known about disorder-asso-
ciated enhanced cognitive processing. Enhanced cognitive processing of
adverse events is one of the most critical elements in the pathology of
major depression that can contribute to the development of stress-re-
lated depressive symptoms (Clark, Chamberlain, & Sahakian, 2009; de
Bitencourt, Pamplona, & Takahashi, 2013; Gold & Korol, 2012; Gold,
Licinio, & Pavlatou, 2012). However, its neurobiological mechanisms
are currently unclear. At the same time, the association between de-
pressive disorders and inflammation has been recognized for some time
(Anthony & Pitossi, 2013; Dantzer, 2009; Leonard & Maes, 2012).
However, it remains unclear as to what aspects of this highly hetero-
geneous disorder inflammation may specifically contribute (Harro,
2019; Michopoulos, Powers, Gillespie, Ressler, & Jovanovic, 2017).
Enhanced acquisition and retention of aversive memories is char-
acteristic of melancholic and anxiety-associated depression (Monzon
et al., 2010) and depression that is comorbid with post-traumatic stress
disorder (PTSD) (Flory & Yehuda, 2015). Positive correlations between
blood levels of C-reactive protein, pro-inflammatory cytokines (such as
interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis
factor (TNF)), as well as cyclooxygenase-1 (COX-1) and the enhanced
learning of aversive memories has been demonstrated in patients with
PTSD (Lindqvist et al., 2017; Miller, Lin, Wolf, & Miller, 2018; Toft
et al., 2019). This condition is well known to share many symptoms
with major depressive disorder and is highly comorbid with this dis-
ease, as well as with generalized anxiety disorder and panic disorder
(Michopoulos, Diaz, & Wilson, 2016). Central overexpression of pro-
inflammatory cytokines functionally interferes with increased activities
of glycogen synthase kinase-3 (GSK-3) and is associated with treatment
resistance in depressed patients with comorbidity for PTSD (Bailey,
Cordell, Sobin, & Neumeister, 2013; Cortés-Vieyra et al., 2012;
Costemale-Lacoste, Guilloux, & Gaillard, 2016). Up-regulation of GSK-3
was shown to be implicated in the processing of aversive memories
during PTSD (Lopresto, Schipper, & Homberg, 2016), and emotional
and cognitive dysregulation during depressive syndrome (Jope & Roh,
2006).
Up to now, very few mechanistic studies have explored the role of
neuroinflammation in the enhanced processing of aversive memories.
While translational approaches have been extensively used to study
depression-related pro-inflammatory changes in models of stress
(Couch et al., 2013, 2016; Patel, Kas, Chattarji, & Buwalda, 2019),
helplessness (Chover-Gonzalez, Jessop, Tejedor-Real, Gibert-Rahola, &
Harbuz, 2000) and other depression paradigms (Dudek et al., 2019;
Mesquita et al., 2008), to date, limited literature described neuroin-
flammatory mechanisms associated with inappropriate learning of
aversive memories in animals. Recently, we established a mouse para-
digm of enhanced contextual conditioning of aversive memories, in
which the classic two-day swimming test is followed by an additional
swim test on Day 5 (Markova et al., 2017; Pavlov et al., 2017;
Strekalova et al., 2016).
In this modified forced swim model (modFST), increased floating
behaviour and GSK-3β expression were exhibited during the delayed
swim session and were found to be context-dependent and reversible by
a pre-treatment with antidepressant compounds (Markova et al., 2017;
Strekalova et al., 2016). In the modFST, the increase of floating beha-
vior during the delayed test on Day 5 correlates with brain over-ex-
pression of GSK-3β and was validated as a biomarker of enhanced
learning of adverse context. Both changes were associated with the
exposure of animals to the context alone and are reversible by pre-
treatment with a low dose of the tricyclic antidepressant imipramine
(Strekalova et al., 2016). While imipramine can ameliorate behavioural
despair in a classic Porsolt test, low doses do not to affect behavioural
outcomes in this test, but in the modFST model they were shown to
prevent an increase of floating and over-expression of GSK-3β on day 5
(Markova et al., 2017; Strekalova et al., 2016). The context of forced
swimming on day 5 alone was also shown to provoke similar molecular
changes with experience of swimming itself, which suggests that clas-
sical Pavlovian contextual conditioning operates in our model.
We hypothesized that augmented contextual conditioning in the
modFST is accompanied by central pro-inflammatory changes.
Therefore, we sought to explore whether expression of IL-1β, TNF and
COX-1 is altered in the hippocampus and prefrontal cortex of mice
exposed to the modFST. As elevated expression of pro-inflammatory
cytokines is often accompanied by increased corticosterone secretion
via activation of the hypothalamic-pituitaryadrenal axis (HPA) axis
(Uchoa et al., 2014) we also studied blood corticosterone concentra-
tions and c-Fos expression, whose over-expression is associated with
increased production of GSK3 and cytokines (Kadry, Abdel-Megeed, El-
Meliegy, & Abdel-Hamid, 2018). Elevated expression of pro-in-
flammatory cytokines in the CNS can also lead to increased oxidative
stress (Sato, Takahashi, Sumitani, Takatsu, & Urano, 2010), and we
evaluated the level of oxidative stress using protein carbonyl content as
a marker (Frijhoff et al., 2015; Vignisse et al., 2017). We applied a two-
week pre-treatment with a low dose of imipramine or thiamine (vitamin
B1), an important metabolism regulator with antioxidant, anti-stress
and anti-inflammatory properties (Bettendorff, Lakaye, Kohn, & Wins,
2014; Gorlova et al., 2019; Mkrtchyan et al., 2015; Pan et al., 2010),
whose chronic administration to mice has been shown to prevented
increased floating behaviour and GSK-3 function in mice subjected to
the modFST (Markova et al., 2017; Pavlov et al., 2017). Imipramine
was included as a ‘positive’ control, besides, it has been reported to
have anti-inflammatory activities in variety of models, (Kamel, Gad,
Mansour, Safar, & Fawzy, 2019; Simões et al., 2019), and particularly,
suppress the over-production of inflammatory cytokines in models of
depression and stress (Duda et al., 2019; Iwata, Ishida, Kaneko, &
Shirayama, 2016; Mudgal et al., 2019).
2. Methods
2.1. Animals
3-month-old male C57BL6/J mice were obtained from Stolbovaja-
RAS, Moscow region (http://www.spf-animals.ru/about/providers/
animals) and housed individually under standard conditions (light on
9.00–21.00). Experimental protocols conformed to directive 2010/63/
EU, and were approved by the local veterinarian committee (MSMU
#11–18-2018; see Supplementary file).
2.2. Experimental outline
Animals were evaluated for their floating behaviour in 6-min ses-
sions split by three 2-min intervals on Day 1, Day 2 and Day 5 and had
tap water (FST group) or were pre-treated with imipramine or thiamine
(Imi-FST and Thi-FST groups) for two weeks, via drinking water; dosing
of selected drug concentrations was controlled as described in
Supplementary file (see also Pavlov et al., 2017). We chose a thiamine
concentration of 200 mg/kg/day and an imipramine concentration of
7 mg/kg/day. The concentration of drugs in water was calculated in
accordance with daily water intake and the body weight of mice, as
described elsewhere (Cline et al., 2012, 2015; Pavlov et al., 2017;
Strekalova, Gorenkova Schunk Dolgov, Bartsch, 2006; Vignisse et al.,
2017). Previous studies employed HPLC analysis of brain levels of
thiamine and its metabolites (Vignisse et al., 2017) and have evaluated
the level of imipramine in blood (Strekalova et al., unpublished data,
2002) and have reported efficacy for the chosen dosing regime. The
regulation of the dose of the selected interventions was controlled as
described in the Supplementary file (see also Pavlov et al., 2017).
Floating behaviour was defined by the absence of any directed
movements of mice and was scored using validated method with
CleverSys (Clever Sys Inc, Reston, VA, USA; Malatynska et al., 2012).
D. Pavlov, et al. Neurobiology of Learning and Memory 172 (2020) 107227
2
Mice subjected to the modFST were killed 10 min after the swim session
on Day 5, which was at the same time as the naïve controls that had not
been not subjected to a swim session, but had been handled on each day
of the test (as for the modFST mice). Mice were terminally anaes-
thetized with an intraperitoneal injection of Nembutal (Bayer,
Wiesbaden, Germany) and were then transcardially perfused with 10 ml
of the ice-cold 0.9% NaCl. Their brains were dissected, and prefrontal
cortex and the whole hippocampus were isolated as described else-
where (Gorlova et al., 2019). Blood serum was collected as described
elsewhere (Couch et al., 2016; Pavlov et al., 2019) and stored at−80 °C
Fig. 1. Experimental outline, potentiated behavioral despair and accompanying brain oxidation and systemic CORT upregulation during delayed swimming session.
(A) After pre-treatment with imipramine or thiamine mice were subjected to 5-day modified swim paradigm and killed; their brains were dissected for in vitro assays,
including quantitative reverse transcription polymerase chain reaction (qRT-PCR) and measurement of carbonyl protein content; blood was collected for mea-
surement of corticosterone levels. (B) On testing Day 2 and 5, total floating behavior was increased in comparison to the one at Day 1. Total duration of floating on
Day 5 was also significantly increased in comparison with Day 2. This parameter was decreased in Thi-FST group in comparison with FST group on Day 5. (C) FST
mice on Day 5 displayed increased systemic CORT level in comparison with controls. Thiamine or imipramine counteracted this effect. (D) FST mice on Day 5
displayed increased protein carbonyl content in the hippocampus and (E) in the prefrontal cortex in comparison with controls. Mice treated with thiamine, but not
imipramine, did not differ from controls in protein carbonyl content in the hippocampus and displayed significant decrease of this measure in comparison with non-
treated group. *p < 0.05 vs. testing Day 1, #p < 0.05 vs. testing Day 2, &p < 0.05 vs. testing Day 5 of FST group, repeated measures and two-way ANOVA, post
hoc Tukey’s test. D1: Day 1; D2: Day 2; D5: Day 5 of modified swim test paradigm. Each group was comprised of 6–7 mice.
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for subsequent in vitro assays; each group had 6–7 animals per ex-
perimental run (Fig. 1A). The correlation analysis between floating
behavior and the other endpoints investigated was carried out; it was
only performed on the mice exposed to the modFST. Both vehicle- and
drug-treated mice exposed to the modFST were included in the corre-
lation analysis. Data from one run was used for all assays except the
correlation analysis between floating behavior and gene expression, for
which cDNA from three experimental runs were used, as described
elsewhere (Pavlov et al., 2017).
2.3. Biochemical assays
CORT ELISA was performed using ab108821 kit (Abcam,
Cambridge, UK) as previously described (Gorlova et al., 2019; Vignisse
et al., 2017), for details see Supplementary file. For protein carbonyl
assay, OxiSelect™ Protein Carbonyl Fluorometric Assay kit (Cell Bio-
labs, Inc., San Diego, CA, USA) kit was used as described elsewhere
(Vignisse et al., 2017; Gorlova et al., 2019, see Supplementary file).
Extraction of mRNA, cDNA synthesis and quantitative RT-PCR were
performed to study brain concentrations of GSK3α/β, IL-1β, TNF, COX-
1 and c-Fos mRNA as described elsewhere (Gorlova et al., 2019; Pavlov
et al., 2017, 2019). Expression data were normalized to glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), used as housekeeping gene, and
calculated as relative-fold changes compared to control mice and in
percent from mean control values. Sequences for primers are listed in
the Supplementary Table 1.
2.4. Statistics
Data were analyzed with GraphPad Prism v.6.0 (San Diego, CA,
USA). Repeated measures ANOVA and two-way ANOVA were used to
analyze the behavioral and the corticosterone data, one-way ANOVA
was applied to analyze the results of the PCR and ELISA assays. Tukey’s
test was used for post-hoc analysis. Spearman correlation was employed
for correlation analysis. The level of confidence was set at 95%
(p < 0.05), data shown as mean and SEM.
3. Results
3.1. Overproduction of brain protein carbonyl and blood CORT accompany
behavioral despair during delayed swim session: effects of imipramine and
thiamine
In the modified forced swim test (modFST), a repeated two-way
ANOVA with session and treatment as factors revealed significant ef-
fects of the sessions on outcome (F2,48 = 14.57, p < 0.0001) and
treatment (F2,48 = 4.218, p = 0.0114), on total duration of floating
(Fig. 1B). A significant effect of sessions, but not treatment, on duration
of floating was found in minutes 1–2 (F2,48 = 10.66, p = 0.0001 and
F2,48 = 1.21, p = 0.307, respectively). For minutes 3–4, a significant
effect on duration of floating of both sessions (F2,48 = 7.27,
p = 0.0017) and treatment (F2,48 = 10.66, p = 0.0001) was revealed.
No significant effect of sessions and treatment on duration of floating
was revealed in minutes 5–6 (F2,48 = 0.38, p = 0.68 and F2,48 = 2.64,
p = 0.08, respectively); there was no significant interaction between
these factors (F2,48 = 0.36, p = 0.83). In all groups, duration of floating
was significantly elevated during the first two time intervals on Day 2 in
comparison to Day 1, that was not shown for the last time interval of
the test (p < 0.05 and p > 0.05, respectively; repeated measures
ANOVA and Tukey’s test¸ Supplementary Table 2). On Day 5, total
duration of floating and duration of floating for 1–2 min interval were
significantly increased in comparison with values registered on Day 2 in
the FST group (p < 0.05; repeated measures ANOVA and Tukey’s test;
Fig. 1B, Supplementary Table 2), but not Imi- or Thi-FST groups
(p > 0.05).
No significant group differences were found in each time interval of
testing, except significantly shortened duration of total floating in Thi-
FST group in comparison with FST mice (Supplementary Table 2).
Together, the analysis of the floating behavior in the 2-min intervals
indicates that the treatments significantly affected the duration of
floating behavior in the first two time intervals of the test, but not
during the last 2 min of the swim session. This may be interpreted as
possible sign of effects of drugs on cognitive factors in this test, rather
than on despair behavior caused by prolonged unescapable swimming.
The overall analysis showed significantly elevated total duration of
floating during delayed session on Day 5, a measure of enhanced con-
textual conditioning in this test was observed in pharmacologically
naïve mice, but not in groups treated with thiamine or imipramine.
There were significant group differences in CORT levels in blood
(F3,38 = 5.48, p = 0.003, one-way ANOVA). Specifically, this measure
was increased in FST mice in comparison with controls (p = 0.04;
Tukey’s test; Fig. 1C). In contrast, CORT levels in Thi-FST and Imi-FST
mice were not different from control values (p = 0.56 and p = 0.27,
respectively) and were significantly decreased in comparison with FST
group (p = 0.006 and p = 0.01, respectively). We found significant
group differences in protein carbonyl contents in the prefrontal cortex
(F3,38 = 6.58, p = 0.002, one-way ANOVA; Fig. 1D) and hippocampus
(F3,38 = 6.209, p = 0.003, Fig. 1E). There was a significant increase of
this measure in the hippocampus and prefrontal cortex of FST group in
comparison with controls (p = 0.025 and p = 0.03, respectively, Tu-
key’s test). No such changes were shown for Imi-FST and Thi-FST
groups (p = 0.44 and p = 0.90, respectively), and the latter but not the
former group displayed a significantly lower protein carbonyl con-
centration in the hippocampus than the FST group (p = 0.406 and
p = 0.01; respectively).
3.2. Brain over-expression of pro-inflammatory factors and c-Fos is
associated with increased floating in the modified swim test and precluded by
thiamine and imipramine
We found significant group differences in mRNA expression of GSK-
3β and GSK-3α in the hippocampus (F3,38 = 4.39, p = 0.008 and
F3,38 = 4.13, p = 0.01, respectively) and of GSK-3β, but not GSK-3α, in
the prefrontal cortex (F3,38 = 3.92, p = 0.03 and F3,38 = 2.35,
p = 0.096, one-way ANOVA). This replicated our previous findings that
also described an upregulation of the gene expression of GSK-3 in the
brain of mice exposed to the modFST (see Supplementary Table 3). There
were significant group differences in IL-1β mRNA expression in the
hippocampus (F3,38 = 3.73, p = 0.01), but not in the prefrontal cortex
(F3,38 = 0.42, p = 0.73; Fig. 2A and B). We observed a significant
increase in the FST group in comparison with control mice in this
measure in the hippocampus but not in the prefrontal cortex (p = 0.04
and p = 0.56, respectively. This effect was counteracted in Imi-FST and
Thi-FST groups vs FST group in hippocampus, while no significant
differences were displayed in Imi-FST and Thi-FST groups vs FST group
in the prefrontal cortex (p = 0.04 and p = 0.02, respectively, and
p = 0.56 and p = 0.72, respectively; Fig. 2A and B). TNF mRNA ex-
pression was significantly different between the groups in the hippo-
campus (F3,38 = 3.64, p = 0.01) and in the prefrontal cortex
(F3,38 = 4.57, p = 0.007). There was a significant increase in the FST
group in comparison with control mice in this measure in the hippo-
campus and in the prefrontal cortex (p = 0.03 and p = 0.01, respec-
tively) that was not found in Imi-FST and Thi-FST groups (p = 0.35 and
p = 0.17, respectively, and p = 0.52 and p = 0.09, respectively;
Fig. 2C and D).
Significant group differences in mRNA expression of COX-1 was
found in the hippocampus (F3,38 = 3.42, p = 0.02), but not in the
prefrontal cortex (F3,38 = 0.84, p = 0.47). In the hippocampus, this
parameter showed a significant increase in the FST group in comparison
with control mice (p = 0.04) that was not found in Imi-FST and Thi-FST
groups (p = 0.28 and p = 0.14, respectively; Fig. 2E and F). Finally,
significant group differences in mRNA expression of c-Fos were shown
D. Pavlov, et al. Neurobiology of Learning and Memory 172 (2020) 107227
4
both in the hippocampus (F3,38 = 5.68, p = 0.002) and prefrontal
cortex (F3,38 = 3.66, p = 0.01); significant over-expression of this gene
was found in FST groups (p = 0.01 and p = 0.03, respectively) but not
in Imi- and Thi-FST groups in comparison with controls (p = 0.55 and
p = 0.97, respectively and p = 0.63 and p = 0.75, respectively; Fig. 2G
and H).
3.3. Correlation analysis of expression of GSK-3 isoforms with behavioral
and molecular alterations during delayed swimming session
Significant correlations were found between GSK-3α expression and
IL-1β expression in the hippocampus (p = 0.04, r = 0.37, Spearman
correlation; Fig. 3A) and TNF expression in the prefrontal cortex
(p = 0.01, r = 0.46; Fig. 3G). There were significant correlations be-
tween GSK-3β expression and expression of IL-1β in the hippocampus
(p = 0.007, r = 0.49; Fig. 3B) and in the prefrontal cortex (p = 0.013,
r = 0.22; Fig. 3D), expression of TNF in the hippocampus (p = 0.02,
r = 0.43; Fig. 3F) and c-Fos expression in the prefrontal cortex
(p = 0.01, r = 0.45; Fig. 3P). No significant correlations were found
between GSK-3α expression and expression of IL-1β in the prefrontal
cortex (p = 0.26, r = −0.21; Fig. 3C), expression of TNF in the hip-
pocampus (p = 0.48, r = −0.19; Fig. 3E), c-Fos expression in the
hippocampus (p = 0.12, r = −0.29; Fig. 3M) and prefrontal cortex
(p = 0.99, r = −0.002; Fig. 3K) and expression of COX-1 in the hip-
pocampus (p = 0.079, r = 0.11; Fig. 3I) and prefrontal cortex
(p = 0.21, r = 0.24; Fig. 3O). Notably, mRNA expression of IL-1β in the
hippocampus positively correlated with total duration of floating
(p = 0.03 r = 0.352; data not shown). No other significant correlations
were found, including correlations between expression of GSK-3β and
other molecules: TNF expression in the prefrontal cortex (p = 0.33,
Fig. 2. Pro-inflammatory changes during
delayed swimming session. Mice on Day 5
displayed increased (A) IL-1β mRNA ex-
pression, (C) TNF expression, (E) COX-1 ex-
pression and (G) c-Fos expression in the
hippocampus in comparison with controls.
Mice treated with imipramine or thiamine
did not differ from controls in these para-
meters and displayed significant decrease of
these measures in comparison with FST
group. Moreover, on Day 5, these mice dis-
played increased (D) TNF expression and (H)
c-Fos expression in the prefrontal cortex in
comparison with controls. Mice treated with
imipramine or thiamine did not differ from
controls in TNF expression and displayed
significant decrease of this measure in com-
parison with non-treated group. At the same
time, only Thi-FST, but not Imi-FST, mice
had significantly decreased c-Fos expression
in the prefrontal cortex in comparison with
FST group. There were no significant dif-
ferences between groups in (A) IL-1β and (F)
COX-1 mRNA levels in the prefrontal cortex.
*p < 0.05 vs. controls, #p < 0.05 vs. non-
treated mice on Day 5; one-way ANOVA and
post hoc Tukey’s test. Each group was com-
prised of 6–7 mice.
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r = 0.19; Fig. 3H), c-Fos expression in the hippocampus (p = 0.06,
r = 0.35; Fig. 3N) and expression of COX-1 in the hippocampus
(p = 0.68, r = 0.079; Fig. 3J) and prefrontal cortex (p = 0.206,
r = 0.13; Fig. 3L).
4. Discussion
To summarize, we found an upregulation of mRNA expression of the
pro-inflammatory mediators IL-1β, TNF and COX-1 in the hippocampus
Fig. 3. Correlation analysis between gene expression of GSK-3 isoforms and stress-associated molecules. (A) Significant correlations were found between GSK-3α
expression and IL-1β expression in the hippocampus and (G) TNF expression in the prefrontal cortex. (B) Significant correlations were also found between GSK-3β
expression and IL-1β expression in the hippocampus and (D) in the prefrontal cortex, (F) TNF expression in the hippocampus and (P) c-Fos expression in the
prefrontal cortex. (C) No significant correlations were found between GSK-3α gene expression and IL-1β expression in the prefrontal cortex, (E) TNF expression in the
hippocampus, (M) c-Fos expression in the hippocampus and (O) prefrontal cortex, (I) COX-1 expression in the hippocampus and (K) in the prefrontal cortex. (H)
There were no significant correlations between GSK-3β expression and TNF expression in the prefrontal cortex, (N) c-Fos expression in the hippocampus, (J) COX-1
expression in the hippocampus and (L) in the prefrontal cortex. p < 0.05, trend line indicates significant correlations; Spearman correlation. Each group was
comprised of 18–25 mice.
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and prefrontal cortex of mice subjected to the modFST, which was
prevented by antidepressant treatments with imipramine or thiamine.
These findings provide the first evidence for the involvement of pro-
inflammatory pathways in an animal model of enhanced learning of
aversive memories and the effects of antidepressant treatments on these
pathways. Furthermore, we found significant correlations of most of
pro-inflammatory changes with key molecular features of the beha-
vioral paradigm that was employed here, particularly the expression of
GSK-3α and GSK-3β; the expression of IL-1β also correlated with
floating behavior. Pro-inflammatory changes were accompanied by
evidence of increased oxidative stress, i.e. increased concentration of
protein carbonyl, in the prefrontal cortex and hippocampus. Markers of
an increased systemic stress response, the CNS over-expression of c-Fos
and hypercorticosteronaemia, were also found in the modFST group.
The majority of these neurobiological abnormalities were prevented by
chronic pre-treatment with low dose of imipramine and administration
of the anti-oxidant and anti-inflammatory thiamine.
We previously reported that in the modFST, increased floating and
brain GSK-3β activities during the additional delayed swim session are
positively correlated and context-dependent (Pavlov et al., 2017;
Strekalova et al., 2016). In accordance with these earlier results, an
increased floating duration and brain GSK-3β over-expression were
prevented by pre-treatment with imipramine or thiamine (Markova
et al., 2017; Pavlov et al., 2017). Detailed behavioural analyses of de-
layed swimming session revealed that there was a significant increase of
floating behavior only during the initial period in comparison with
pharmacologically naïve mice. This suggests that exposure to aversive
context of swimming, not unescapable swimming itself, was likely to be
the cause of this increase. Such increase was not found in pharmaco-
logically-treated groups, which was in keeping with our previous results
(Markova et al., 2017; Pavlov et al., 2017).
Given the established links between stress-induced release of glu-
cocorticoids and elevated GSK-3 activities (Beurel, Grieco, & Jope,
2015), both of which were observed in our study, and pro-inflammatory
consequences of the latter (Chang et al., 2013; Huang et al., 2009), we
suggest that over-expression of IL-6, TNF and COX-1 in the modFST
results from these changes. Elevated GSK-3 activities have been pre-
viously shown to inhibit the expression of calcium-responsive-element-
binding protein (CREB) and the anti-inflammatory cytokine IL-10
(Huang et al., 2009), and promote the expression of proinflammatory
cytokines via activation of nuclear factor-κB (NF-κB) (Chang et al.,
2013). In contrast, the blockade of Toll-like receptor 4 (TLR4), a major
mediator of inflammatory processes (Buchanan, Hutchinson, Watkins,
& Yin, 2010) during psychological stress in mice, ameliorated GSK-3
activities and depressive-like symptoms (Cheng et al., 2016).
Over the years, most attention has focused on the role of central IL-
1β expression in the generation of sickness behavior, and IL-1β sig-
naling pathways in the brain are accepted as having an important role
in the induction of depressive-like changes in behavior (D'Mello &
Swain, 2017; Gądek-Michalska, Tadeusz, Rachwalska, & Bugajski,
2013). Over-expression of IL-1β in the brain has been shown to corre-
late with an individual’s predisposition to stress-induced anhedonia in
mice (Couch et al., 2013) and accompany the depressive syndrome
induced in other models in mice and rats (Cordeiro et al., 2019; Fang
et al., 2019), including the ultrasound stress model of “emotional
stress” (Gorlova et al., 2019; Morozova et al., 2016; Pavlov et al., 2017).
The present study revealed the up-regulation of this cytokine both in
the pre-frontal cortex and in the hippocampus, and there was a corre-
lation with floating behavior and overexpression of GSK-3β in the
prefrontal cortex. Notably, overproduction of IL-1β has been described
in individuals with PTSD (Toft et al., 2019; Wang, Caughron, & Young,
2017) indicating its translational potential.
TNF, another cytokine studied in our work here, was over-expressed
in the brain of mice exposed to modFST. The potential for TNF to
contribute to mood disorders has gained attention based on the basal
‘antidepressant’ phenotype of TNF and TNF receptor knockout mice
(Simen, Duman, Simen, & Duman, 2006), “pro-hedonic” effects of tar-
geted deletion of TNF receptor 2 in sucrose intake test (Yamada et al.,
2000) and there is evidence that TNF blockade can reduce signs of
depression (Krügel, Fischer, Radicke, Sack, & Himmerich, 2013). The
present study revealed a link between TNF over-expression and aug-
mented learning of adverse memories that is in line with clinical data
suggesting altered TNF expression during PTSD and depression (Miller
et al., 2018; Passos et al., 2015; Yuan, Chen, Xia, Dai, & Liu, 2019).
Our study also revealed an increase in gene expression of hippo-
campal COX-1, which previously appeared to accompany the develop-
ment of stress-induced anhedonia in mice (Couch et al., 2013). In line
with these findings, mice lacking COX-1 were reported to be resilient to
social stress-induced anhedonia (Tanaka et al., 2012). COX-1 was found
to be over-expressed in depressed patients as well as in patients with
acute PTSD (Michopoulos et al., 2019; Passos et al., 2015; Powers et al.,
2019). The correlation between the molecular markers and floating
behavior in the modFST does not imply causation, but suggests that a
functional relationship is likely to exist between the molecular changes
and regulation of the modFST behavior and acquisition of aversive
memories. This was particularly marked for the pro-inflammatory cy-
tokines and both isoforms of GSK3, which replicate our previous find-
ings.
Here, we demonstrated that administration of imipramine and
thiamine exerted central anti-inflammatory and anti-oxidative stress
effects in the modFST. These treatments were previously shown to
normalize depressive- and anxiety-like behaviours, GSK-3 expression,
markers of oxidative stress and hippocampal cell proliferation during
predation stress, the ultrasound model of emotional stress and the
modFST (Cline et al., 2012, 2015; Gorlova et al., 2019; Pavlov et al.,
2017; Vignisse et al., 2017). As indicated above, imipramine was in-
cluded as a ‘positive’ control and a pharmacological reference for
comparison with the thiamine intervention, which has also been re-
ported to have anti-inflammatory activities. SSRIs are also reported to
have anti-inflammatory effects, and, if the mice had been treated with
an SSRI, they may also have had similar, beneficial effects, but has been
reported to evoke weak changes in the forced swimming behavior of
naïve laboratory rodents (Strekalova et al., 2006).
As over-production of cytokines, including TNF has been shown to
stimulate glutamate release from astrocytes (Bezzi et al., 2001) and
microglia (Takeuchi et al., 2006) that might result in excessive in-
tracellular calcium, leading to activation of calcium-dependent lipases
and up-regulation of reactive oxygen species (Dargelos et al., 2010),
these mechanisms could explain the increases in brain oxidative stress
markers that appear during the modFST. Administration of thiamine or
imipramine ameliorated protein carbonyl levels in the brain, suggesting
an improvement in the balance of direct oxidation processes by reactive
oxygen species (ROS) of amino acid residues (Cecarini et al., 2007).
These data are in keeping with the literature suggesting compromised
markers of oxidative stress during depression and comorbid disorders
such as PTSD, anxiety disorders and their normalization by anti-
depressant treatment (Berk et al., 2013; Miller et al., 2018).
Finally, the above-mentioned effects of treatments were accom-
panied by lowered c-Fos expression in the hippocampus and prefrontal
cortex of experimental animals that suggests activity-dependent nor-
malizing changes in these brain structures and may be due to previously
reported functional links to oxidative stress, GSK3, and neuroin-
flammatory mechanisms (Kadry et al., 2018; Rana & Singh, 2018).
5. Conclusions
Taken together, our study suggests that the development of en-
hanced contextual conditioning of adverse memories in the modFST
mouse paradigm is associated with a proinflammatory profile and signs
of oxidative stress. These changes are likely to be due to increases in
blood glucocorticoid levels and GSK-3 activities (Thoeringer et al.,
2012). Given that patients with symptoms of depression and PTSD
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disorders displayed signs of neuroinflammation (Michopoulos et al.,
2017), it might be anticipated that the treatments investigated here
may have therapeutic potential, not only for prevention of associated
symptoms, but also for the treatment of the condition. Our findings are
in line with clinical data on the pathophysiology of depression, sug-
gesting that depression of distinct forms leads to elevated levels of in-
flammation and an oxidant/antioxidant imbalance (Ogłodek & Just,
2018), as well as emphasize a role for neuroinflammatory processes
during augmented learning of aversive memories (Miller et al., 2018).
They further validate the modFST model as a tool for studying in-
appropriate learning of aversive memory in the pathophysiology of
depressive syndromes and highlight future directions for the develop-
ment of novel therapeutics targeting oxidative stress and inflammation
in patients with related psychopathologies.
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